The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.

Newsletter Jan 2017

Latest Newsletter with the new members of the Scientific Advisory Committee, the public World RePort data base with funding data from NIH, MRC UK, SIDA, EDCTP and other funders and the Ditect-HAT project on diagnostics for sleeping sickness.

Read more

Eighth EDCTP Forum

We published the highlights of the Eighth EDCTP Forum in Lusaka, Zambia from 6-9 November 2016

Forum abstracts were published in BMJ Global Health







Read more

UK APPG meeting

Published! – Read the summary of the UK APPG meeting on ‘EDCTP: African-European partnership for global health benefit’, which took place in London, UK on 27 February 2017.

Read more

Latest news

25 April 2017

Funding research and innovation to help end malaria

The fight against malaria has seen a decade of remarkable success and progress. It remains, however, a threat to half…

Read more
24 March 2017

World TB day 2017: closing the gaps to end tuberculosis

Ending the tuberculosis (TB) epidemic by 2030 is one of the health targets of the Sustainable Development Goals. Although TB…

Read more